Premal Lulla

20PUBLICATIONS
110CO-AUTHORS
Predictive and prognostic markersCardiology (incl. cardiovascular diseases)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Aug 14, 2025
New comorbidity index associated with survival after chimeric antigen receptor T-cell therapy for large B-cell lymphoma.

Uri Greenbaum, Hamza Hashmi, Mahmoud Elsawy

|Oct 29, 2024
Hematopoietic cell transplant compared with standard care in adolescents and young adults with sickle cell disease.

Mark C Walters, Mary Eapen, Yiwen Liu

|Jan 19, 2024
Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia.

Wingchi K Leung, Alejandro G Torres Chavez, Matthew French-Kim

|Jan 10, 2024
The remission status of AML patients after allo-HCT is associated with a distinct single-cell bone marrow T-cell signature.

Anna Mathioudaki, Xizhe Wang, David Sedloev

|Dec 25, 2023
Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas.

LaQuisa C Hill, Rayne H Rouce, Mengfen J Wu

|Jan 11, 2023
Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting.

Thomas Pfeiffer, Ifigeneia Tzannou, Mengfen Wu

Pageof 4

Frequent Collaborators

8 joint publications

Helen E Heslop

8 joint publications

LaQuisa Hill

7 joint publications

Carlos Ramos

5 joint publications

Wang Tao